| Strategic International Session4（S）(JSGE) |
| Sat. November 2nd 9:00 - 11:30 Room 11: Portopia Hotel South Wing Topaz |
| Colorectal Cancer screening. Adjusting to new trends | |||
| Xavier Llor | |||
| Department of Medicine (Digestive Diseases), Yale School of Medicine | |||
|
|||
|
|||
| Colorectal Cancer (CRC) screening has been widely adopted in the US over the last 40 years and it is credited for the observed steady decrease in CRC incidence and mortality. Nevertheless, >30% of the eligible population has not been screened. Part of the reason for this is that we have heavily relied on colonoscopy screening which is an invasive test that requires time off from work and bowel preparation. Supported by data showing that offering different screening options and offering shared decision making with the patient results in better compliance, there has been a growing interest in proposing alternative options and more emphasis has been placed on stool-based tests. At the same time, blood based tests have also started to appear with the promise of a more universally accepted screening approach. With the recent recognition of the increasing incidence of CRC among young individuals (before screening age), and the cohort effect that carries on in individuals born after the early 1960's, there has been an important shift in attitudes and overall recalibration of CRC in the US. Thus, as the level of awareness of this fact has caused a significant increase in diagnostic colonoscopies for younger individuals, this is resulting in a more stressed system regarding colonoscopy availability. A way forward is to risk stratify individuals which should allow for a more comprehensive use of non-colonoscopy screening approaches, particularly among individuals with lower CRC risk. |
|||
|
Index Term 1: Colorectal cancer screening Index Term 2: Colorectal cancer incidence |
|||
| Page Top | |||